These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18206113)

  • 1. Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases.
    Nakano T; Nakajima K; Niimi M; Fujita MQ; Nakajima Y; Takeichi S; Kinoshita M; Matsushima T; Teramoto T; Tanaka A
    Clin Chim Acta; 2008 Apr; 390(1-2):38-43. PubMed ID: 18206113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases.
    Nakajima K; Nakajima Y; Takeichi S; Fujita MQ
    Atherosclerosis; 2007 Oct; 194(2):473-82. PubMed ID: 17045270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
    Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
    Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
    Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
    Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of rabbit apolipoprotein B by use of electroimmunodiffusion and immunonephelometric assays.
    Tailleux A; Labbe J; Mallet C; Percevault F; Fruchart JC; Fievet C
    Comp Med; 2000 Jun; 50(3):309-13. PubMed ID: 10894498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid and lipoprotein profiles of apo B-carrying particles in remnant-like lipoproteins isolated from plasma in sudden cardiac death cases.
    Nakajima Y; Takeichi S; Osawa M; Nakajima K; Nakano T; Fujita MQ
    Tokai J Exp Clin Med; 2006 Dec; 31(4):160-6. PubMed ID: 21302248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of apolipoprotein B-48 in serum by a sandwich ELISA.
    Kinoshita M; Kojima M; Matsushima T; Teramoto T
    Clin Chim Acta; 2005 Jan; 351(1-2):115-20. PubMed ID: 15563879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.
    Masuda D; Nakagawa-Toyama Y; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Sandoval JC; Ohama T; Nishida M; Ishigami M; Yamashita S
    Eur J Clin Invest; 2009 Aug; 39(8):689-98. PubMed ID: 19490064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immuno-morphologic detection of specific APO-B antigenic determinants in normal intima and atherosclerotic plaques in the human aorta].
    Shekhonin BV; Tararak EM; Kovaleva EA; Ianushevskaia EV; Trakht IN
    Arkh Patol; 1989; 51(2):23-30. PubMed ID: 2469412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein B-48: a unique marker of chylomicron metabolism.
    Nakajima K; Nagamine T; Fujita MQ; Ai M; Tanaka A; Schaefer E
    Adv Clin Chem; 2014; 64():117-77. PubMed ID: 24938018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta.
    Mucchiano GI; Häggqvist B; Sletten K; Westermark P
    J Pathol; 2001 Feb; 193(2):270-5. PubMed ID: 11180176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.
    Olofsson SO; Borèn J
    J Intern Med; 2005 Nov; 258(5):395-410. PubMed ID: 16238675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidity and lipolysis by group V secreted phospholipase A(2) strongly increase the binding of apoB-100-containing lipoproteins to human aortic proteoglycans.
    Lähdesmäki K; Öörni K; Alanne-Kinnunen M; Jauhiainen M; Hurt-Camejo E; Kovanen PT
    Biochim Biophys Acta; 2012 Feb; 1821(2):257-67. PubMed ID: 22041135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B retention in the grossly normal and atherosclerotic human aorta.
    Hoff HF; Heideman CL; Gotto AM; Gaubatz JW
    Circ Res; 1977 Nov; 41(5):684-90. PubMed ID: 332407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
    Fredrikson GN; Lindholm MW; Ljungcrantz I; Söderberg I; Shah PK; Nilsson J
    Autoimmunity; 2007 Mar; 40(2):122-30. PubMed ID: 17453711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.
    Lee DM; Alaupovic P; Knight-Gibson C; Bagdade JD
    Eur J Clin Invest; 2008 Oct; 38(10):734-42. PubMed ID: 18761668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.
    Tascilar N; Dursun A; Ankarali H; Mungan G; Sumbuloglu V; Ekem S; Bozdogan S; Baris S; Aciman E; Cabuk F
    J Neurol Sci; 2009 Feb; 277(1-2):17-21. PubMed ID: 18945448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased apolipoprotein deposits in early atherosclerotic lesions distinguish symptomatic from asymptomatic patients.
    Wyler von Ballmoos M; Dubler D; Mirlacher M; Cathomas G; Muser J; Biedermann BC
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):359-64. PubMed ID: 16322531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.